Table of Contents Author Guidelines Submit a Manuscript
International Journal of Inflammation
Volume 2017, Article ID 7840150, 10 pages
https://doi.org/10.1155/2017/7840150
Review Article

Are Systematic Screening for Vitamin D Deficiency and Vitamin D Supplementation Currently Feasible for Ankylosing Spondylitis Patients?

1Department of Internal Medicine and Specialties, Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon
2Department of Medicine, Groote Schuur Hospital and University of Cape Town, Cape Town, South Africa

Correspondence should be addressed to Mickael Essouma; moc.liamtekcor@cimsse

Received 3 September 2016; Revised 29 October 2016; Accepted 24 November 2016; Published 2 January 2017

Academic Editor: Kamyar Kalantar-Zadeh

Copyright © 2017 Mickael Essouma and Jean Jacques N. Noubiap. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Van den Berg, X. Baraliakos, J. Braun, and D. Van der Heijde, “First update of the current evidence for the management of ankylosing spondylitis with non-pharmacological treatment and non-biologic drugs: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis,” Rheumatology, vol. 51, no. 8, pp. 1388–1396, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. D. I. Daikh and P. P. Chen, “Advances in managing ankylosing spondylitis,” F1000Prime Reports, vol. 6, article 78, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Stolwijk, M. van Onna, A. Boonen, and A. van Tubergen, “Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis,” Arthritis Care & Research, vol. 68, no. 9, pp. 1320–1331, 2016. View at Publisher · View at Google Scholar
  4. J. D. Reveille, “Biomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis,” Clinical Rheumatology, vol. 34, no. 6, pp. 1009–1018, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Baraliakos and J. Braun, “Spondyloarthritides,” Best Practice and Research: Clinical Rheumatology, vol. 25, no. 6, pp. 825–842, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. L. E. Dean, G. T. Jones, A. G. Macdonald, C. Downham, R. D. Sturrock, and G. J. Macfarlane, “Global prevalence of ankylosing spondylitis,” Rheumatology, vol. 53, no. 4, Article ID ket387, pp. 650–657, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. T.-C. Shen, C.-L. Lin, C.-C. Wei et al., “The risk of asthma in patients with ankylosing spondylitis: a population-based cohort study,” PLoS ONE, vol. 10, no. 2, Article ID 0116608, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Ungprasert, N. Srivali, and W. Kittanamongkolchai, “Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis,” Annals of Translational Medicine, vol. 3, no. 4, article 51, 2015. View at Google Scholar
  9. N. Nigil Haroon, J. Sriganthan, N. Al Ghanim, R. D. Inman, and A. M. Cheung, “Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis,” Seminars in Arthritis and Rheumatism, vol. 44, no. 2, pp. 155–161, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Braun, R. Van Den Berg, X. Baraliakos et al., “2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 70, no. 6, pp. 896–904, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. M. Ward, A. Deodhar, E. A. Akl et al., “American college of rheumatology/spondylitis Association of America/spondyloarthritis research and treatment network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis,” Arthritis Care & Research, vol. 68, no. 2, pp. 151–166, 2016. View at Google Scholar
  12. J. A. Reynolds and I. N. Bruce, “Vitamin D treatment for connective tissue diseases: hope beyond the hype?” Rheumatology, 2016. View at Publisher · View at Google Scholar
  13. M. G. Balvers, E. M. Brouwer-Brolsma, S. Endenburg, L. C. de Groot, F. J. Kok, and J. K. Gunnewiek, “Recommended intakes of vitamin D to optimise health, associated circulating 25-hydroxyvitamin D concentrations, and dosing regimens to treat deficiency: workshop report and overview of current literature,” Journal of Nutritional Science, vol. 4, article no. e23, 2015. View at Publisher · View at Google Scholar
  14. M. Essouma and J. J. N. Noubiap, “Is air pollution a risk factor for rheumatoid arthritis?” Journal of Inflammation, vol. 12, article no. 48, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Mousa, M. Misso, H. Teede, R. Scragg, and B. de Courten, “Effect of vitamin D supplementation on inflammation: protocol for a systematic review,” BMJ Open, vol. 6, no. 4, Article ID e010804, 2016. View at Publisher · View at Google Scholar
  16. M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari et al., “Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline,” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 7, pp. 1911–1930, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. IOM (Institute of Medicine), Dietary Reference Intakes for Calcium and Vitamin D, The National Academies Press, Washington, DC, USA, 2011.
  18. S. Erten, O. Kucuksahin, A. Sahin, A. Altunoglu, M. Akyol, and C. Koca, “Decreased plasma vitamin D levels in patients with undifferentiated spondyloarthritis and ankylosing spondylitis,” Internal Medicine, vol. 52, no. 3, pp. 339–344, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Durmus, Z. Altay, O. Baysal, and Y. Ersoy, “Does vitamin D affect disease severity in patients with ankylosing spondylitis?” Chinese Medical Journal, vol. 125, no. 14, pp. 2511–2515, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Zhao, S. J. Duffield, R. J. Moots, and N. J. Goodson, “Systematic review of association between vitamin D levels and susceptibility and disease activity of ankylosing spondylitis,” Rheumatology, vol. 53, no. 9, pp. 1595–1603, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Klingberg, G. Oleröd, O. Hammarsten, and H. Forsblad-d’Elia, “The vitamin D status in ankylosing spondylitis in relation to intestinal inflammation, disease activity, and bone health: a cross-sectional study,” Osteoporosis International, vol. 27, no. 6, pp. 2027–2033, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. I. Hmamouchi, F. Allali, B. E. Handaoui et al., “The relation between disease activity, vitamin D levels and bone mineral density in men patients with ankylosing spondylitis,” Rheumatology Reports, vol. 5, no. 1, article e3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Yazmalar, L. Ediz, M. Alpayci, O. Hiz, M. Toprak, and I. Tekeoglu, “Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis,” African Health Sciences, vol. 13, no. 1, pp. 47–55, 2013. View at Google Scholar · View at Scopus
  24. B. Mermerci Başkan, Y. Pekin Doğan, F. Sivas, H. Bodur, and K. Özoran, “The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis,” Rheumatology International, vol. 30, no. 3, pp. 375–381, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. U. Lange, J. Teichmann, J. Strunk, U. Müller-Ladner, and K. L. Schmidt, “Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis,” Osteoporosis International, vol. 16, no. 12, pp. 1999–2004, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. B. M. Obermayer-Pietsch, U. Lange, G. Tauber et al., “Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis,” Osteoporosis International, vol. 14, no. 12, pp. 995–1000, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. U. Lange, O. Jung, J. Teichmann, and G. Neeck, “Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis,” Osteoporosis International, vol. 12, no. 12, pp. 1031–1035, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Franck and E. Keck, “Serum osteocalcin and vitamin D metabolites in patients with ankylosing spondylitis,” Annals of the Rheumatic Diseases, vol. 52, no. 5, pp. 343–346, 1993. View at Publisher · View at Google Scholar · View at Scopus
  29. G. G. Pokhai, S. Bandagi, and A. Abrudescu, “Vitamin D levels in ankylosing spondylitis: does deficiency correspond to disease activity?” Revista Brasileira de Reumatologia, vol. 54, no. 4, pp. 330–334, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Guillot, L. Semerano, N. Saidenberg-Kermanac'h, G. Falgarone, and M.-C. Boissier, “Vitamin D and inflammation,” Joint Bone Spine, vol. 77, no. 6, pp. 552–557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Helming, J. Böse, J. Ehrchen et al., “1α,25-dihydroxyvitamin D3 is a potent suppressor of interferon γ-mediated macrophage activation,” Blood, vol. 106, no. 13, pp. 4351–4358, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. P. T. Liu, S. Stenger, H. Li et al., “Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response,” Science, vol. 311, no. 5768, pp. 1770–1773, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. M.-C. Boissier, E. Assier, J. Biton, A. Denys, G. Falgarone, and N. Bessis, “Regulatory T cells (Treg) in rheumatoid arthritis,” Joint Bone Spine, vol. 76, no. 1, pp. 10–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Daniel, N. A. Sartory, N. Zahn, H. H. Radeke, and J. M. Stein, “Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile,” Journal of Pharmacology and Experimental Therapeutics, vol. 324, no. 1, pp. 23–33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. S. V. Ramagopalan, R. Goldacre, G. Disanto, G. Giovannoni, and M. J. Goldacre, “Hospital admissions for vitamin D related conditions and subsequent immune-mediated disease: record-linkage studies,” BMC Medicine, vol. 11, no. 1, article no. 171, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Arends, A. Spoorenberg, G. A. W. Bruyn et al., “The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis,” Osteoporosis International, vol. 22, no. 5, pp. 1431–1439, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Cai, L. Wang, D. Fan et al., “Vitamin D in ankylosing spondylitis: review and meta-analysis,” Clinica Chimica Acta, vol. 438, pp. 316–322, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Rashid and A. Ebringer, “Ankylosing spondylitis is linked to Klebsiella—the evidence,” Clinical Rheumatology, vol. 26, no. 6, pp. 858–864, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Peelen, S. Knippenberg, A.-H. Muris et al., “Effects of vitamin D on the peripheral adaptive immune system: a review,” Autoimmunity Reviews, vol. 10, no. 12, pp. 733–743, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Magrey and M. A. Khan, “Osteoporosis in ankylosing spondylitis,” Current Rheumatology Reports, vol. 12, no. 5, pp. 332–336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. C. Van Der Weijden, T. A. M. Claushuis, T. Nazari, W. F. Lems, B. A. C. Dijkmans, and I. E. Van Der Horst-Bruinsma, “High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review,” Clinical Rheumatology, vol. 31, no. 11, pp. 1529–1535, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. E. Klingberg, M. Lorentzon, D. Mellström et al., “Osteoporosis in ankylosing spondylitis-prevalence, risk factors and methods of assessment,” Arthritis Research and Therapy, vol. 14, no. 3, article R108, 12 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. K. Briot, B. Cortet, T. Thomas et al., “Actualisation 2012 des recommandations françaises du traitement médicamenteux de l’ostéoporose post-ménopausique,” Revue du Rhumatisme, vol. 79, no. 3, pp. 264–274, 2012. View at Publisher · View at Google Scholar
  44. S. Mathieu, L. Gossec, M. Dougados, and M. Soubrier, “Cardiovascular profile in ankylosing spondylitis: a systematic review and meta-analysis,” Arthritis Care & Research, vol. 63, no. 4, pp. 557–563, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. C. McGreevy and D. Williams, “New insights about vitamin D and cardiovascular disease: a narrative review,” Annals of Internal Medicine, vol. 155, no. 12, pp. 820–826, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. A. C. Ross, J. E. Manson, S. A. Abrams et al., “The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 1, pp. 53–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Vieth, “Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety,” The American Journal of Clinical Nutrition, vol. 69, no. 5, pp. 842–856, 1999. View at Google Scholar · View at Scopus
  48. H. Ziaie, S. Razmjou, R. Jomhouri, and A. Jenabi, “Vitamin D toxicity; Stored and released from adipose tissue?” Archives of Iranian Medicine, vol. 19, no. 8, pp. 597–600, 2016. View at Google Scholar
  49. R. Vieth, “The mechanisms of vitamin D toxicity,” Bone and Mineral, vol. 11, no. 3, pp. 267–272, 1990. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Robien, S. J. Oppeneer, J. A. Kelly, and J. M. Hamilton-Reeves, “Drug-vitamin D interactions: a systematic review of the literature,” Nutrition in Clinical Practice, vol. 28, no. 2, pp. 194–208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Alshahrani and N. Aljohani, “Vitamin D: deficiency, sufficiency and toxicity,” Nutrients, vol. 5, no. 9, pp. 3605–3616, 2013. View at Publisher · View at Google Scholar · View at Scopus